RESUMEN
Sodium diethyldithiocarbamate (DETC) is the main metabolite of disulfiram. Recently, we reported that mechanism of disulfiram cytotoxicity in V79 cells might be partially connected with thiol redox-state imbalance. Here, we examined the effect of DETC on the level of intracellular glutathione (GSH), protein oxidation (measured as PC-protein carbonyl content), lipid peroxidation (measured as TBARS-thiobarbituric acid reactive substances), antioxidant enzymatic defense, as well as on apoptosis. We used V79 Chinese hamster fibroblasts cells with and without modulated glutathione (GSH) level by N-acetyl-L-cysteine (NAC). We showed that treatment with DETC at concentrations that cause a moderate increase in thiol-state imbalance but not cell death stimulates oxidative stress measured as increased level of PC and TBARS, adaptive response of GSH-related enzymes and apoptosis. Our results show that cellular effects of DETC are partially attributable to the initial redox cellular state, since the increase of GSH level by NAC pre-treatment prevented the observed changes.
Asunto(s)
Antioxidantes/metabolismo , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Ditiocarba/toxicidad , Fibroblastos/efectos de los fármacos , Glutatión/metabolismo , Animales , Anexina A5 , Catalasa/metabolismo , Línea Celular , Proliferación Celular/efectos de los fármacos , Colorimetría , Colorantes , Cricetinae , Fragmentación del ADN/efectos de los fármacos , Disulfiram/toxicidad , Fibroblastos/enzimología , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Etiquetado Corte-Fin in Situ , Peroxidación de Lípido/efectos de los fármacos , Carbonilación Proteica , Sustancias Reactivas al Ácido Tiobarbitúrico , Azul de TripanoRESUMEN
Joint formation is a developmental process regulated by various factors including bone morphogenetic proteins, transforming and growth factors, etc. Recently, a high expression of cyclooxygenase (COX) isoforms in the foetal cartilaginous elements was also revealed. On the other hand, various joint and skeletal abnormalities were seen in laboratory animal and human offspring, exposed in utero to several COX inhibitors. Immunoexpression of constitutive (COX-1) and inducible (COX-2) cyclooxygenase isoforms was evaluated in various articular structures of untreated and unfamiliar 21-day-old male rat foetuses. Both COX isoforms were detected in the articular cartilage and joint capsule, as well as in the intra-articular disc of the temporomandibular joint and meniscus of the knee joint. COX-1 immunostaining was revealed in the anterior and posterior cruciate ligament of the knee joint and the labrum of the hip and shoulder, whereas COX-2 immunoreactivity in those structures was not found. It could be concluded that both constitutive and inducible COX isoforms are physiologically expressed in various structures of synovial joints in rat foetuses at the end of prenatal development.
Asunto(s)
Ciclooxigenasa 1/metabolismo , Ciclooxigenasa 2/metabolismo , Feto/enzimología , Articulaciones/embriología , Articulaciones/enzimología , Membrana Sinovial/embriología , Membrana Sinovial/enzimología , Animales , Cartílago Articular/citología , Cartílago Articular/embriología , Cartílago Articular/enzimología , Isoenzimas/metabolismo , Articulaciones/citología , Ligamentos/citología , Ligamentos/embriología , Ligamentos/enzimología , Masculino , Ratas , Ratas Wistar , Membrana Sinovial/citologíaRESUMEN
The role of antioxidant defence systems in protection against oxidative damage of lipids and proteins induced by fungicide thiram during in vitro exposure was investigated in cultured Chinese hamster V79 cells with normal, depleted, and elevated glutathione (GSH) levels. We analyzed the catalytic activities of superoxide dismutases (SOD1 and SOD2), Se-dependent and Se-independent glutathione peroxidases (GSH-Px), glutathione reductase (GR), and catalase (CAT), as well as total glutathione/glutathione disulfide ratio (GSH(total)/GSSG). Thiram treatment resulted in an increase in activities of SOD1, Se-dependent GSH-Px, and GR at the highest tested dose (150 microM). On the contrary, inhibition of CAT and Se-independent GSH-Px activities, and no significant changes in the level of SOD2 activity was observed at any tested doses (100-150 microM). GSH(total)/GSSG ratio in the 100 microM thiram treated cells was not significantly changed comparing to the control, despite significant decrease of GSH total (50%). In 150 microM thiram treated cells the ratio falls to 43% of control value. Pretreatment with l-buthionine sulfoximine (L-BSO), an inhibitor of GSH synthesis, significantly enhanced decrease in CAT and Se-independent GSH-Px activities, as well as GSH(total)/GSSG ratio, and reduced Se-dependent GSH-Px activity, following exposure to thiram. Simultaneously, L-BSO pretreatment enhanced increase in SOD1 activity, and had no effect on SOD2, following thiram exposure. Pretreatment with N-acetyl cysteine (NAC), a GSH precursor, prevented enzymatic changes in CAT, Se-dependent GSH-Px, GR, SOD1 activities, and significantly decreased SOD2 activity following exposure to thiram. GSH(total)/GSSG ratio was restored to the control value. This study suggests that following the changes in antioxidant defense systems thiram can act through the production of free radicals.
Asunto(s)
Antioxidantes/metabolismo , Fibroblastos/efectos de los fármacos , Fungicidas Industriales/toxicidad , Tiram/toxicidad , Animales , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Línea Celular , Cricetinae , Cricetulus , Relación Dosis-Respuesta a Droga , Fibroblastos/metabolismo , Radicales Libres/metabolismo , Fungicidas Industriales/administración & dosificación , Glutatión/metabolismo , Disulfuro de Glutatión/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/efectos de los fármacos , Glutatión Reductasa/metabolismo , Técnicas In Vitro , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Superóxido Dismutasa-1 , Tiram/administración & dosificaciónRESUMEN
Constitutive (COX-1) and inducible (COX-2) cyclooxygenase isoforms have been detected in various mammalian tissues. Their activity is blocked by non-steroidal anti-inflammatory drugs that may induce various side reactions. The aim of the study was to evaluate the effects of DFU, a selective COX-2 inhibitor, on exocrine and endocrine pancreatic function and the immunoexpression of both COX isoforms in maternal and foetal rat pancreases. The compound was administered to pregnant Wistar rats once daily from the 8th to the 21st day of gestation. Glucose level and amylase activity were determined in the maternal sera. Maternal and foetal pancreases were examined histologically. Immunoexpression of COX-1 and COX-2 was also evaluated. Both biochemical parameters, as well as the histological structure of the pancreas were undisturbed in the dams and their foetuses. The maternal glucose level was found to be an important factor for foetal growth. Strong cytoplasmic COX-1 immunostaining was observed in acinar secretory cells, whereas in islets the immune reaction was weak. Endocrine cells also revealed strong cytoplasmic COX-2 staining in the maternal and foetal pancreases. Acinar cells exhibited nuclear reaction, which was strong in the foetal but weak in the maternal pancreases. No differences in COX immunoexpression were found between the DFU-exposed and the control groups in either mothers or foetuses. It should be stressed that DFU administered throughout mid and late pregnancy in rats did not change maternal or foetal pancreatic morphology or immunoexpression of either of the main COX isoforms in the organ.
Asunto(s)
Inhibidores de la Ciclooxigenasa 2/farmacología , Desarrollo Fetal/fisiología , Furanos/farmacología , Páncreas/fisiología , Amilasas/metabolismo , Animales , Peso Corporal/efectos de los fármacos , Ciclooxigenasa 1/metabolismo , Ciclooxigenasa 2/metabolismo , Femenino , Desarrollo Fetal/efectos de los fármacos , Glucosa/metabolismo , Isoenzimas/metabolismo , Masculino , Páncreas/efectos de los fármacos , Páncreas/enzimología , Embarazo , Ratas , Ratas WistarRESUMEN
Fungicide thiram, which is also known as an inducer of allergic contact dermatitis (ACD), was used as a model compound of thiuram chemicals, and its cellular effects were investigated in cultured Chinese hamster V79 cells. The level of intracellular reduced glutathione (GSH), protein sulfhydryl (PSH) groups, protein carbonyls (PC), membrane lipid peroxidation reflected by enhanced thiobarbituric acid reactive substrates (TBARS) production, as well as apoptotic effect were determined. The apoptosis induction was determined by assessing DNA fragmentation by TUNEL, annexin V binding, and caspases activation assays, using fluorescent microscope or flow cytometry, respectively. The concentrations of thiram required to induce cellular GSH depletion (by 40-50%), protein, and membrane lipid peroxidation (2-fold, and 1.7-fold, respectively), as well as to induce apoptosis in V79 Chinese hamster fibroblasts without causing necrosis through cytotoxic effects were between 50-100 microM. To investigate the role of decreased GSH content in the toxicity of thiram, GSH level was modified prior to exposure. Pretreatment of V79 cells with N-acetyl-L-cysteine (NAC), a GSH biosynthesis precursor, prevented GSH decrease, PC and TBARS production, as well as caspases activation induced by thiram exposure. On the other hand, thiram effects were enhanced by the previous depletion of cellular GSH by L-buthionine-(S,R)-sulfoximine (BSO).
Asunto(s)
Apoptosis/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Fungicidas Industriales/farmacología , Glutatión/deficiencia , Tiram/farmacología , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Cricetinae , Relación Dosis-Respuesta a Droga , Fibroblastos/metabolismo , Fungicidas Industriales/toxicidad , Glutatión/metabolismo , Dosificación Letal Mediana , Peroxidación de Lípido/efectos de los fármacos , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Proteínas/metabolismo , Compuestos de Sulfhidrilo/metabolismo , Tiram/toxicidadRESUMEN
The genotoxic activity of environmental xenobiotics is manifested either in their direct interaction with cellular genetic material or in provoking secondary events, among which reactive oxygen species (ROS) production is a common phenomenon. Both pathways can be mediated by the activity of the cytochrome P450 monooxygenase system. We studied induction of the CYP 1A or CYP 2B monooxygenases in rat liver by the fungicides: thiram, captan, captafol, dodine and the drugs: nitrofurazone, furazolidone and the plant flavonoid: quercetin. A cytochrome P450 induction assay (CYPIA test) was used. S9 prepared from livers of rats treated with the test compounds were used to activate ethidium bromide (EtBr) (CYP 1A isoenzyme) or cyclophosphamide (CPA) (CYP 2B isoenzyme) in the Ames test. It was found that among the tested compounds, the most potent inducer of CYP 1A was furazolidone (3 x 80 mg/kg). Less potent was thiram (1 x 100mg/kg), as well as quercetin (3 x 80 mg/kg), and captafol (1 x 30 mg/kg). On the other hand, thiram (1 x 100 mg/kg), captafol (1 x 30 mg/kg), and quercetin (3 x 80 mg/kg) were most potent in the CYP 2B isoenzyme induction, while furazolidone (3 x 80 mg/kg), and nitrofurazone (3 x 80 mg/kg) appeared to be less potent in this respect. Captan and dodine (3 x 80 mg/kg) did not affect the activity of any of the cytochrome P450 isoenzymes.
Asunto(s)
Sistema Enzimático del Citocromo P-450/biosíntesis , Fungicidas Industriales/farmacología , Microsomas Hepáticos/efectos de los fármacos , Nitrofuranos/farmacología , Quercetina/farmacología , Animales , Carcinógenos/farmacología , Relación Dosis-Respuesta a Droga , Inducción Enzimática/efectos de los fármacos , Etidio/farmacología , Isoenzimas/biosíntesis , Masculino , Metilcolantreno/farmacología , Microsomas Hepáticos/enzimología , Pruebas de Mutagenicidad , Fenobarbital/farmacología , Ratas , Ratas WistarRESUMEN
Daminozide [ALAR] a plant growth regulator has been widely used on apples since the late 1960s. It has been identified as a possible carcinogen. Restrictions were ordered to reduce both application rates and allowable daminozide residue levels. Since conclusive scientific data necessary to characterize the risk of daminozide were not available, additional information on mutagenic activity of this compound was needed.
Asunto(s)
ADN Bacteriano/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Reguladores del Crecimiento de las Plantas/toxicidad , Salmonella typhimurium/efectos de los fármacos , Succinatos/toxicidad , Fosfatasa Alcalina/efectos de los fármacos , Animales , Escherichia coli/enzimología , Hígado/efectos de los fármacos , Masculino , Pruebas de Mutagenicidad , Ratas , Ratas Wistar , Salmonella typhimurium/genética , Especificidad de la Especie , beta-Galactosidasa/efectos de los fármacosRESUMEN
The mutagenic activity of captan and captafol was tested using Ames strains and strains showing an SOS response. Captafol was mutagenic in S. typhimurium strain TA102 (uvr+) and captan in strain TA104 (uvrB). Both captan and captafol elicit damages in DNA recognized by correndonuclease II, as shown by the repair test, and induced the SOS repair system in E. coli PQ37 (uvrA) strain. Only captafol induced the SOS system in PQ35 (uvr+). The lack of induction of beta-galactosidase at nonpermissive temperature in E. coli MD332 (dnaCs uvrA) strain showed that neither chemical was able to produce DNA breaks. In V79 Chinese hamster fibroblasts higher induction of c-mitosis by captafol than by captan (22% and 15% over the control, respectively) was accompanied by a higher decrease in nonprotein sulfhydryl groups, mainly GSH (41% and 77%, respectively). The content of protein sulfhydryl groups was decreased by either fungicide to a similar extent.
Asunto(s)
Captano/análogos & derivados , Captano/farmacología , Escherichia coli/efectos de los fármacos , Fungicidas Industriales/farmacología , Mitosis/efectos de los fármacos , Salmonella typhimurium/efectos de los fármacos , Animales , Línea Celular , Cricetinae , Cricetulus , Ciclohexenos , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Pruebas de Mutagenicidad , Respuesta SOS en Genética/efectos de los fármacos , Salmonella typhimurium/genética , Especificidad de la Especie , Compuestos de Sulfhidrilo/metabolismoRESUMEN
During compensatory growth of kidney, microsomal lipid peroxidation is unchanged in the hypertrophy phase and is doubled in a period of hyperplasia. The maximum lipid peroxidation is preceded by a 2-fold increase in the content of cytochrome P-450. Both in microsomes and cytosol, intense peroxidation of lipids is accompanied by a decrease in glutathione content.
Asunto(s)
Riñón/metabolismo , Peróxidos Lipídicos/biosíntesis , Animales , Ácido Ascórbico/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Glutatión/metabolismo , Hipertrofia/metabolismo , Riñón/patología , Masculino , Microsomas/metabolismo , Ratas , Ratas EndogámicasRESUMEN
1. Ribosomes isolated from hypertrophic kidneys were examined at different time intervals after unilateral nephrectomy. The activity of ribosomes measured by [14C] leucine incorporation and synthesis of polyphenylalanine from [14C]Phe-tRNA, was increased after 24 h, whereas changes in the composition of ribosomal protein fractions appeared as early as within 6 hours after the operation. 2. In hypertrophic kidney the content of ribosomes increased but the ratio of free and membrane-bound ribosomes remained practically unaltered. However, the specific activity of free ribosomes was twice as high as that of bound ribosomes. 3. It is concluded that the enhanced activity of free ribosomes is one of the factors responsible for the increased protein synthesis in hypertrophic kidney.